ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2025: 46.83%

ADMA Biologics, Inc. Return on Assets (ROA) is 46.83% for the Trailing 12 Months (TTM) ending March 31, 2025, a -4,507.71% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2024 was -1.06%, a -94.23% change year over year.
  • ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2023 was -18.42%, a -45.06% change year over year.
  • ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2022 was -33.52%, a -7.69% change year over year.
  • ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2021 was -36.31%, a 3.14% change year over year.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share